Beth Anne Tarini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beth Anne Tarini has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
Dimitri A. Christakis
8 shared publications- Brian J. Zikmund-Fisher
Department of Health Behavior and Health Equity, University of Michigan, Ann Arbor, MI, USA
6 shared publications - Aaron J. Goldenberg
Case Western Reserve University School of Medicine Cleveland Ohio USA
5 shared publications Benjamin S. Wilfond
Child Health Evaluation and Research Unit, Division of General Pediatrics, Department of Pediatrics & Communicable Diseases, University of Michigan, Lombardi Comprehensive Cancer Center, Department of Oncology, Department of Pediatrics, Georgetown University School of Medicine, Treuman Katz Center for Pediatric Bioethics, Seattle Children's Hospital, and Department of Pediatrics, University of Washington School of Medicine
3 shared publications- Colin M. Sox
Division of General Academic Pediatrics, Department of Pediatrics, Boston Medical Center & Boston University School of Medicine (CM Sox), Boston, Mass
3 shared publications H. Gilbert Welch
Veterans Affairs Outcomes Group White River Junction, VT 05009 Center for the Evaluative Clinical Sciences Dartmouth Medical School Hanover, NH 03755
3 shared publications
Latest Publications
- Open Access
- 13 May 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 197 (9) , e64115
Parental Communication With their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and Counseling
Cascade genetic testing for cancer risk can influence relatives' health outcomes, as they may benefit from risk reduction and screening. However, clinical guidelines discourage predictive genetic testing in childhood—including direct‐to‐consumer (DTC) testing. This study examined high‐risk parents' preparation of their children (primarily adolescents and young adults) for cascade genetic testing for adult‐onset inherited cancers. Surveys were completed by N = 126 parents with pathogenic variants predisposing to adult‐onset inherited cancers included on DTC testing panels. A total of 81% of children were aware of their parents' hereditary cancer predisposition and 62% of parents had discussed their children's participation in cancer genetic testing. Potential risks of DTC testing identified by parents included lack of engagement with clinicians; potential benefits were its usefulness for child/family health and convenience. Parents with older children (B = 0.07, p = < 0.001), greater confidence in using genetic information (B = 0.02, p < 0.05), and who held more favorable opinions about pediatric genetic testing (B = 0.02, p < 0.01) were more likely to make their children aware of their familial cancer risk and discuss cascade testing. Most high‐risk parents discuss hereditary cancer and testing options with their older children. Research is needed to enrich understanding of healthcare professionals' roles in navigating the implications of cascade genetic testing choices within the family, including DTC testing.
- 13 May 2025
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 197 (9) , e64115
Open AccessParental Communication With their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and Counseling
Cascade genetic testing for cancer risk can influence relatives' health outcomes, as they may benefit from risk reduction and screening. However, clinical guidelines discourage predictive genetic testing in childhood—including direct‐to‐consumer (DTC) testing. This study examined high‐risk parents' preparation of their children (primarily adolescents and young adults) for cascade genetic testing for adult‐onset inherited cancers. Surveys were completed by N = 126 parents with pathogenic variants predisposing to adult‐onset inherited cancers included on DTC testing panels. A total of 81% of children were aware of their parents' hereditary cancer predisposition and 62% of parents had discussed their children's participation in cancer genetic testing. Potential risks of DTC testing identified by parents included lack of engagement with clinicians; potential benefits were its usefulness for child/family health and convenience. Parents with older children (B = 0.07, p = < 0.001), greater confidence in using genetic information (B = 0.02, p < 0.05), and who held more favorable opinions about pediatric genetic testing (B = 0.02, p < 0.01) were more likely to make their children aware of their familial cancer risk and discuss cascade testing. Most high‐risk parents discuss hereditary cancer and testing options with their older children. Research is needed to enrich understanding of healthcare professionals' roles in navigating the implications of cascade genetic testing choices within the family, including DTC testing.
- Open Access
- 2 December 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (12) , e2448676
Estimated Radon Exposure in Eastern Pennsylvania Schools
This cross-sectional study examines publicly available data to estimate school-based radon and radiation dose exposure to children attending school in 5 eastern Pennsylvania districts to estimate children’s annual additional risk as a result of those locations.
- 2 December 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (12) , e2448676
Open AccessEstimated Radon Exposure in Eastern Pennsylvania Schools
This cross-sectional study examines publicly available data to estimate school-based radon and radiation dose exposure to children attending school in 5 eastern Pennsylvania districts to estimate children’s annual additional risk as a result of those locations.
- 1 October 2023
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 177 (10) , 1007-1008
The Krabbe Conundrum Is Really a Newborn Screening Conundrum
In this issue of JAMA Pediatrics, Bailey1 argues that “The Krabbe conundrum is a harbinger of a future in which most screening decisions will be difficult and contentious….” We disagree. Krabbe disease is not a harbinger of the future—it is the exemplar of newborn screening (NBS) in the 21st century. The issues Bailey highlights (paucity of harms data, narrow benefit construct, and the calculus of net benefit) are NBS—not Krabbe—conundrums, and they have surfaced during the review of nearly every condition added to the Recommended Uniform Screening Panel (RUSP) since its 2010 inception—and before. These conundrums remain unsolved because they are fueled by persistent structural and societal factors: a quasi-mandatory population-based child screening program with limited parental consent, the clinical challenges of screening for rare disease in a population, and ongoing technological advances in testing and therapeutics. Solving these conundrums will require broadening NBS’s role to one that embraces a learning health system model.2
- 1 October 2023
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 177 (10) , 1007-1008
The Krabbe Conundrum Is Really a Newborn Screening Conundrum
In this issue of JAMA Pediatrics, Bailey1 argues that “The Krabbe conundrum is a harbinger of a future in which most screening decisions will be difficult and contentious….” We disagree. Krabbe disease is not a harbinger of the future—it is the exemplar of newborn screening (NBS) in the 21st century. The issues Bailey highlights (paucity of harms data, narrow benefit construct, and the calculus of net benefit) are NBS—not Krabbe—conundrums, and they have surfaced during the review of nearly every condition added to the Recommended Uniform Screening Panel (RUSP) since its 2010 inception—and before. These conundrums remain unsolved because they are fueled by persistent structural and societal factors: a quasi-mandatory population-based child screening program with limited parental consent, the clinical challenges of screening for rare disease in a population, and ongoing technological advances in testing and therapeutics. Solving these conundrums will require broadening NBS’s role to one that embraces a learning health system model.2
- 12 May 2022
- Published by Springer Nature
- p. 149-156
Research, Funding, and Publication for Women in Pediatrics
- 12 May 2022
- Published by Springer Nature
- p. 149-156
Research, Funding, and Publication for Women in Pediatrics
- 1 March 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 242, 12-17.e1
Pediatrician Adherence to Guidelines for Diagnosis and Management of High Blood Pressure
- 1 March 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 242, 12-17.e1
Pediatrician Adherence to Guidelines for Diagnosis and Management of High Blood Pressure
- 15 February 2022
- Published by Taylor & Francis in Health Communication
- Vol. 38 (9) , 1821-1846
Healthcare team communication training in the United States: A scoping review
The purpose of this literature review was to identify interventions designed to improve healthcare team communication in the United States. We conducted a review of peer-reviewed, English-language articles describing interventions aimed at improving healthcare team communication. We analyzed articles that met pre-specified inclusion and exclusion criteria and characterized who is testing communication interventions, the rationale for testing, and ways of measuring effectiveness. We descriptively categorized the strength and types of study findings. Thirty articles were retained in our analysis. Most assessments were conducted by academic medical centers, the Veterans Health Administration, and teaching hospitals. Interventions sought to improve teamwork, patient safety, clinical outcomes, costs of care, and enhance provider job satisfaction and well-being. Intervention strategies included didactic lectures, simulation, Crew Resource Management, quality improvement, or a combination of these approaches. The vast majority employed a pre-post survey design and measured outcomes using participant feedback. Many assessments failed to utilize a social science theory or communication-specific measures. Interventions with the best training content were conducted at academic medical centers, used a pre-post design, and utilized statistical analysis to analyze results. While interventions for improving healthcare team communication are diverse and have uneven effectiveness, early markers of success merit continued development and assessment.
- 15 February 2022
- Published by Taylor & Francis in Health Communication
- Vol. 38 (9) , 1821-1846
Healthcare team communication training in the United States: A scoping review
The purpose of this literature review was to identify interventions designed to improve healthcare team communication in the United States. We conducted a review of peer-reviewed, English-language articles describing interventions aimed at improving healthcare team communication. We analyzed articles that met pre-specified inclusion and exclusion criteria and characterized who is testing communication interventions, the rationale for testing, and ways of measuring effectiveness. We descriptively categorized the strength and types of study findings. Thirty articles were retained in our analysis. Most assessments were conducted by academic medical centers, the Veterans Health Administration, and teaching hospitals. Interventions sought to improve teamwork, patient safety, clinical outcomes, costs of care, and enhance provider job satisfaction and well-being. Intervention strategies included didactic lectures, simulation, Crew Resource Management, quality improvement, or a combination of these approaches. The vast majority employed a pre-post survey design and measured outcomes using participant feedback. Many assessments failed to utilize a social science theory or communication-specific measures. Interventions with the best training content were conducted at academic medical centers, used a pre-post design, and utilized statistical analysis to analyze results. While interventions for improving healthcare team communication are diverse and have uneven effectiveness, early markers of success merit continued development and assessment.
- Open Access
- 28 January 2022
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 8 (1) , 11
Genomics and Newborn Screening: Perspectives of Public Health Programs
This study assesses the benefits and challenges of using genomics in Newborn Screening Programs (NBS) from the perspectives of State program officials. This project aims to help programs develop policies that will aid in the integration of genomic technology. Discussion groups were conducted with the NBS Program and Laboratory Directors in the seven HRSA Regional Genomics Collaboratives (August 2014–March 2016). The discussion groups addressed expected uses of genomics, potential benefits, and challenges of integrating genomic technology, and educational needs for parents and other NBS stakeholders: Twelve focus groups were conducted, which included participants from over 40 state programs. Benefits of incorporating genomics included improving screening modalities, supporting diagnostic procedures, and screening for a wider spectrum of disorders. Challenges included the costs of genomics, the ability to educate parents and health care providers about results, and the potential negative psychosocial impact of genomic information. Attempts to address the challenges of integrating genomics must focus on preserving the child welfare goals of NBS programs. Health departments will need to explore how genomics could be used to enhance programs while maintaining universal access to screening.
- 28 January 2022
- Published by MDPI AG in International Journal of Neonatal Screening
- Vol. 8 (1) , 11
Open AccessGenomics and Newborn Screening: Perspectives of Public Health Programs
This study assesses the benefits and challenges of using genomics in Newborn Screening Programs (NBS) from the perspectives of State program officials. This project aims to help programs develop policies that will aid in the integration of genomic technology. Discussion groups were conducted with the NBS Program and Laboratory Directors in the seven HRSA Regional Genomics Collaboratives (August 2014–March 2016). The discussion groups addressed expected uses of genomics, potential benefits, and challenges of integrating genomic technology, and educational needs for parents and other NBS stakeholders: Twelve focus groups were conducted, which included participants from over 40 state programs. Benefits of incorporating genomics included improving screening modalities, supporting diagnostic procedures, and screening for a wider spectrum of disorders. Challenges included the costs of genomics, the ability to educate parents and health care providers about results, and the potential negative psychosocial impact of genomic information. Attempts to address the challenges of integrating genomics must focus on preserving the child welfare goals of NBS programs. Health departments will need to explore how genomics could be used to enhance programs while maintaining universal access to screening.
- 1 November 2021
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 175 (11) , 1107-1108
The Effect of BabySeq on Pediatric and Genomic Research—More Than Baby Steps
In this issue of JAMA Pediatrics, Pereira et al1 report on a sizable group of healthy newborns screened with whole-exome sequencing (WES) shortly after birth whose world—and the world of their parents—did not end in psychological and emotional Armageddon (so far). Does this mean that we are ready to offer WES to each of the 4 million infants born annually in the US? No. Does it mean that we have made a critical first step in understanding the potential benefits and harms of screening newborns with WES? Absolutely. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 1 November 2021
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 175 (11) , 1107-1108
The Effect of BabySeq on Pediatric and Genomic Research—More Than Baby Steps
In this issue of JAMA Pediatrics, Pereira et al1 report on a sizable group of healthy newborns screened with whole-exome sequencing (WES) shortly after birth whose world—and the world of their parents—did not end in psychological and emotional Armageddon (so far). Does this mean that we are ready to offer WES to each of the 4 million infants born annually in the US? No. Does it mean that we have made a critical first step in understanding the potential benefits and harms of screening newborns with WES? Absolutely. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.
- 24 September 2021
- Published by Elsevier in Child Abuse & Neglect
- Vol. 122, 105334
Clusters of adverse childhood experiences and unmet need for care coordination
- 24 September 2021
- Published by Elsevier in Child Abuse & Neglect
- Vol. 122, 105334
Clusters of adverse childhood experiences and unmet need for care coordination
- Open Access
- 13 August 2021
- Published by Springer Nature in Pediatric Research
- Vol. 91 (1) , 264
Correction: The american pediatric society and society for pediatric research joint statement against racism and social injustice
- 13 August 2021
- Published by Springer Nature in Pediatric Research
- Vol. 91 (1) , 264
Open AccessCorrection: The american pediatric society and society for pediatric research joint statement against racism and social injustice